Audit finds mistakes but no legal violation in Covid-19 vaccine procurement
An external investigation into the Swiss government’s procurement of Covid-19 vaccines has revealed that two contracts with vaccine manufacturers were signed prior to parliament’s sign-off of funds. However, this didn’t constitute a legal violation.
This content was published on
2 minutes
Keystone-SDA/jdp
Português
pt
Auditoria encontra erros, mas nenhuma violação legal na aquisição da vacina contra a Covid-19
Health minister Alain Berset requested the external investigationExternal link when questions were raised in summer 2022 about whether parliament could agree to a supplementary loan for the procurement of more Covid-19 vaccines. The government administration began to scrutinise all credits and vaccine contracts, uncovering two cases whereby contracts with vaccine manufacturers were not covered by the credits.
In one case the contract was signed with a manufacturer in May 2021 but parliament didn’t approve the necessary funds until June 7, 2021.
The external investigation, publishedExternal link on Wednesday, which was carried out by a former head of the Swiss federal audit office, confirmed the original findings by the government administration “in full”, but indicated that no legal or contractual obligations had “been intentionally violated”.
The investigation also revealed though that not all contracts ensured that parliament could change the orders without violating contractual obligations.
It was also critical of how the government managed credits and offered ten recommendations for the future. This included involving people involved in finance more closely.
In June 2022, the government was forced to slash its order for more Covid-19 vaccines in half to seven million doses after parliament said the order was excessive for a population of 8.7 million people. In May the Federal Office of Public Health confirmed that around 620,000 doses of Moderna vaccine in its existing stockpile had been destroyed because they had expired.
Authorities have ordered 36 million doses from Pfizer/BioNTech, Moderna, AstraZeneca, Curevac and Novavax. In August 2021, the government signed a deal with Pfizer/BioNTech to supply vaccines for the next two years.
Young undocumented migrants gain easier access to vocational training
This content was published on
Rejected asylum-seekers and young undocumented migrants in Switzerland will have easier access to basic vocational training from June 1.
Migration: Swiss government wants to shorten reunification period for families
This content was published on
Family members of people temporarily admitted to Switzerland should in future be able to join them after two years instead of three.
This content was published on
2023 was a record year for the Rhaetian Railway in several respects. Never before has the narrow-gauge railway in Graubünden, eastern Switzerland, transported so many passengers and cars.
Swiss CFOs much more optimistic despite global uncertainty
This content was published on
The main concerns of business leaders in Switzerland are geopolitical uncertainty and the important trading partners Germany and China.
Record organ donation in Switzerland despite high rejection rates
This content was published on
More organ donations were recorded in Switzerland in 2023 than ever before. This was despite a high rejection rate of 58% by surviving relatives.
This content was published on
Seven years after the death of record-breaking Swiss mountain climber Ueli Steck, his estate is going to the Alpine Museum of Switzerland in Bern.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.